Xtant Medical Holdings (XTNT) Cash from Investing Activities (2010 - 2025)

Xtant Medical Holdings' (XTNT) quarterly Cash from Investing Activities came in at $4.7 million in Q3 2025, up 332.9% year-on-year from $1.1 million in Q3 2024, and up 1576.03% on a QoQ basis from -$317000.0 in Q2 2025.

Xtant Medical Holdings (XTNT) Cash from Investing Activities (2010 - 2025) Analysis & Trends

Xtant Medical Holdings (XTNT) has 16 years of Cash from Investing Activities data on file, last reported at $4.7 million in Q3 2025.

  • On a quarterly basis, Cash from Investing Activities rose 332.9% year-over-year to $4.7 million in Q3 2025; TTM through Sep 2025 was $2.7 million, a 148.43% increase from a year earlier, with the FY2024 full-year figure at -$3.7 million, up 84.95% from the prior year.
  • Cash from Investing Activities for Q3 2025 stood at $4.7 million, up from -$317000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for XTNT reached as high as $4.7 million in Q3 2025 and fell as low as -$17.4 million in Q1 2023.
  • Historically, Cash from Investing Activities has averaged -$1.5 million across 5 years, with a median of -$483000.0 in 2021.
  • Across the five-year window, Cash from Investing Activities plunged 4355.5% in 2023 and soared 332.9% in 2025, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$595000.0 in 2021, then climbed by 29.08% to -$422000.0 in 2022, then tumbled by 448.1% to -$2.3 million in 2023, then jumped by 75.49% to -$567000.0 in 2024, then jumped by 925.22% to $4.7 million in 2025.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $4.7 million in Q3 2025, -$317000.0 in Q2 2025, and -$1.1 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -20.32 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -185.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -92.80 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -298.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -475.32 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -2.50 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Xtant Medical Holdings 5.69 Mn -11.63 Mn 17.75 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 4.68 Mn
Sep 30, 2025 4.68 Mn
Jun 30, 2025 -317,000.00
Jun 30, 2025 -317,000.00
Mar 31, 2025 -1.14 Mn
Mar 31, 2025 -1.14 Mn
Dec 31, 2024 -567,000.00
Dec 31, 2024 -567,000.00
Sep 30, 2024 -2.01 Mn
Sep 30, 2024 -2.01 Mn
Jun 30, 2024 -480,000.00
Jun 30, 2024 -480,000.00
Mar 31, 2024 -674,000.00
Mar 31, 2024 -674,000.00
Dec 31, 2023 -2.31 Mn
Dec 31, 2023 -2.31 Mn
Sep 30, 2023 -4.66 Mn
Sep 30, 2023 -4.66 Mn
Jun 30, 2023 -394,000.00
Jun 30, 2023 -394,000.00